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Abstract
Purpose—Crosslinked, degradable derivatives of low-molecular-weight polyethylenimine (PEI)
are relatively efficient and non-cytotoxic gene delivery agents. To further investigate these
promising materials, a new synthetic approach was developed using a poly(4-vinylpyridine)-
supported Fe(III) catalyst (PVP(Fe(III))) that provides more facile synthesis and enhanced control
of polymer molecular weight.
Methods—Biodegradable polymers (D.PEI) comprising 800-Da PEI crosslinked with 1,6-
hexanediol diacrylate and exhibiting molecular weights of 1.2, 6.2, and 48 kDa were synthesized
utilizing the PVP(Fe(III)) catalyst. D.PEI/DNA polyplexes were characterized using gel
retardation, ethidium bromide exclusion, heparan sulfate displacement, and dynamic light
scattering. In vitro transfection, cellular uptake, and cytotoxicity of the polyplexes were tested in
human cervical cancer cells (HeLa) and human breast cancer cells (MDA-MB-231).
Results—D.PEIs tightly complexed plasmid DNA and formed 320- to 440-nm diameter
polyplexes, similar to those comprising non-degradable, 25-kDa, branched PEI. D.PEI polyplexes
mediated 2- to 5-fold increased gene delivery efficacy compared to 25-kDa PEI and exhibited
20% lower cytotoxicity in HeLa and no toxicity in MDA-MB-231. In addition, 2- to 7-fold
improved cellular uptake of DNA was achieved with D.PEI polyplexes.
Conclusions—PVP(Fe(III)) catalyst provided a more controlled synthesis of D.PEIs, and these
materials demonstrated improved in vitro transfection efficacy and reduced cytotoxicity.
Keywords
polyethylenimine; non-viral gene delivery; biodegradable polymer; polymer supported ferric
chloride
Introduction
Gene therapy is a promising technique for treating diseases that are caused by genetic
mutations, which can lead to malfunction or deficiency of proteins. For example, intractable
diseases such as hemophilia, cystic fibrosis, and severe combined immunodeficiency (SCID)
are related to specific aberrant genetic mutations (1–2). Currently, the most challenging
aspect of gene therapy is delivery of therapeutic genes into target cells and/or tissues
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efficiently and without significant side effects. Most current gene delivery methods suffer
critical drawbacks that have prevented gene therapies from getting past the clinical trial
development phase (3–4). New materials providing safe and effective gene delivery are
required to advance gene therapy into the clinic (5–7).
Polyethylenimine (PEI) is one of the most studied cationic polymers in gene delivery due to
its commercial availability and relatively high in vitro transfection efficiency. PEI exhibits
high primary, secondary, and tertiary amine densities, allowing easy ligand functionalization
to enhance cell targeting and uptake (8–9). The 25-kDa, branched form of PEI has been
shown to provide high transfection efficiency in vitro, but its high cytotoxicity prevents it
from being used clinically. As a result, branched PEI has been relegated to use as a model
material and as a standard to compare transfection efficacy of gene delivery materials. Much
research has been done to modify or functionalize branched PEI to reduce polymer toxicity
while improving gene delivery efficacy and cellular uptake.
In general, transfection efficiency is directly related to the molecular weight of PEI, while
toxicity is inversely related. Gosselin et al. demonstrated that 25-kDa PEI displays gene
delivery efficiency 50-fold higher than 800-Da PEI but reduces cell viability by more than
half (10). Since toxicity should be one of the major considerations in any gene delivery
vector’s design, researchers have explored various alternatives to temporarily increase the
molecular weight of low molecular weight cationic polymers. The resulting polymers can
condense DNA and possess gene delivery efficiency similar to their high molecular weight
counterparts and degrade into a less toxic low molecular weight version of the polymers
inside the cells. One way to accomplish this goal is to cross-link low molecular weight PEI,
which is relatively non-toxic, with a degradable cross-linker. Many synthetic approaches
have been investigated using different cross-linker-polymer combinations, resulting in
biodegradable polymers possessing reduced cytotoxicity and improved transfection
efficiency. Examples of successful cross-linkers include an acid-labile imine linker between
1.8-kDa PEI and glutaraldehyde, degradable chitosan-linked PEI copolymer, and disulfide
cross-linked PEI (11–13). These results indicate that the cross-linking design can be crucial
for synthesizing degradable synthetic gene delivery vectors that show both low toxicity and
high efficiency.
One of the strategies used in synthesizing degradable polycations is the Michael addition of
amines to acrylate groups. Lynn et al. first screened a library of 140 diacrylate cross-linked
amine polymers, showing some specific combinations of diacrylates and amine monomers
with promising transgene expression (14). Forrest et al. later described the synthesis of
biodegradable PEI derivatives by cross-linking 800-Da, branched PEI with 1,3-butanediol
diacrylate or 1,6-hexanediol diacrylate. The resulting degradable PEI derivatives showed
two- to 16-fold increase in transfection efficiency compared to 25-kDa, branched PEI and
were also essentially non-toxic (15). However, the synthesis procedure was reported to be
inconsistent and difficult to control.
In the present study, we report an alternative facile synthesis of biodegradable PEI (D.PEI)
derivatives by Michael addition utilizing poly(4-vinylpyridine) (PVP)-supported ferric
chloride (PVP(Fe(III))) heterogenous catalyst. Fe(III) has the ability to catalyze the
diacrylate cross-linking reaction, but separating it from PEI post-synthesis is difficult due to
PEI’s metal chelating potential (16). By incorporating a polymer support, the PVP(Fe(III))
provides a low-cost, heterogeneous catalyst that allows easy catalyst recovery (17). As a
result, this alternative synthesis scheme provides a more controllable PEI cross-linking
method and D.PEIs with wider range of molecular weights, as well as enhanced transfection
properties.
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All chemicals were purchased from Sigma Aldrich (St Louis, MO) unless otherwise
specified.
Cells and Plasmids
The MDA-MB-231 human breast carcinoma cell line was purchased from the American
Type Culture Collection (Manassas, VA). The HeLa human cervical carcinoma cell line was
a gift from Dr. Sandra McMasters (University of Illinois, Urbana, IL). Cells were cultured
according to their ATCC protocols at 37 °C and 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM). The growth medium was supplemented with 10% fetal bovine serum
(FBS) and 1% penicillin-streptomycin. The 5.3-kilobase expression vector pGL3 (Promega,
Madison, WI), coding for firefly luciferase gene driven by the SV40 promoter and enhancer,
was produced by Elim Biopharm (Hayward, CA) and used without further purification.
PVP(Fe(III)) Catalyst and Biodegradable PEI Syntheses
Polymer supported ferric chloride was synthesized by suspending 1 g of poly(4-
vinylpyridine) (PVP) in 10 mL of 0.1 M FeCl3 solution in double-distilled water in a
scintillation vial. An additional 1 mmol of FeCl3 was added into the mixture and stirred at
room temperature for 30 minutes. The PVP-immobilized Fe(III) solid was filtered under
vacuum, washed with double-distilled water, and dried at 60°C overnight.
D.PEI was synthesized by cross-linking 800-Da branched PEI with 1,6-hexanediol
diacrylate cross-linker. Briefly, 1 g of 800-Da branched PEI was dissolved in 10 mL of
methanol at room temperature in a scintillation vial. Various molar equivalents of
PVP(Fe(III)) catalyst to mole of PEI, between 0.05 to 0.15, in addition to an equimolar
amount of cross-linker to PEI, were added into the mixture to form a suspension. The
mixture was sealed and stirred for 24 h, and centrifuged at 4500 rpm for 10 min to remove
the catalyst. Unreacted materials were extracted using petroleum ether. The methanol was
removed by using a rotating evaporator at 67 °C and 150 rpm for 25 min until only viscous
D.PEI sample was left. The final polymer sample was used without further purification and
stored at −80 °C.
Polymer Characterizations
1H NMR (Variant Unity 400) was used to examine the structure and cross-linking density of
D.PEI in D2O. The extent of cross-linking was determined by peak integration at: δ=1.25–
1.40 ppm (br m, -COOCH2CH2CH2, 2 H, ester linker), δ=1.40–1.60 ppm (br m, -
COOCH2CH2, 2 H, ester linker), δ=2.33–2.47 ppm (br m, CH2CH2NHCH2CH2COOCH2, 2
H, ester linker), δ=2.47–3.3 ppm (br m, CH2CH2N, PEI ethylenes), δ=3.5–3.6 ppm
(t, 3J=6.6MHz, -HOCH2, 2 H, hydrolyzed ester linker), and δ=4.1 ppm (m, -COOCH2, 2H,
ester linker). For the cross-linked PEI degradation study, each sample was dissolved in D2O
and incubated at 37 °C for 0 h, 24 h, 72 h, and 192 h, and the 1H-NMR spectrum was
acquired using the same apparatus. The fraction of remaining cross-linked PEI was
determined by integrating and comparing the ester peaks at δ=4.1 ppm (m, -COOCH2, 2H,
ester linker) and δ=3.5–3.6 ppm (t, 3J=6.6MHz, -HOCH2, 2 H, hydrolyzed ester linker).
Molecular weight of D.PEI was determined using capillary viscometry (18). Briefly,
polymers were dissolved in 0.5 M NaNO3 to achieve three different solutions with
concentrations between 1 to 5 g/L, and the viscosities were measured using a kinematic
viscometer (Cannon, State College, PA) at 25 °C. Based on the measurements, reduced,
specific, inherent, and limiting viscosities of the polymer solution were calculated. By
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plotting the Staudinger-Mark-Houwink relationship with known molecular weight PEI
standards, the molecular weight of each D.PEI sample was calculated based on the sample’s
viscosity.
Polyplex Formation
For polyplex characterization, 1 μg of DNA was diluted in PIPES buffer (120 mM NaCl, 16
mM PIPES at pH 7.2) and mixed with various amounts of polymer, dissolved in double
distilled water, to form the desired polymer and DNA weight–to-weight ratio polyplexes.
For polyplexes used for in vitro transfection, 0.5 μg of DNA was used to form polyplexes
instead. Each polyplex sample was incubated at room temperature for 15 min after
formation before any additional experiments were performed.
Polyplex Gel Retardation
After the 15 min incubation at room temperature, DNA sample buffer (Bio-Rad, Hercules,
CA) was added into the polyplexes. The samples were electrophoresed on a 1% agarose gel
for 30 min at 120 V. The gel was visualized with ethidium bromide (Bio-Rad, Hercules,
CA) staining.
Ethidium Bromide Exclusion Assay
Ethidium bromide (0.5 μg) was added into each polyplex sample in a 96-well microplate
and incubated at room temperature for an additional 10 min. Fluorescence was excited at
510 nm and emission detected at 595 nm in a Synergy 2 Multi-Mode Fluorescence
Microplate Reader (Bio Tek, Winooski, VT). The sample fluorescence value was
normalized by values for wells containing DNA only, after subtracting background
fluorescence measured from wells containing ethidium bromide only. Each measurement
was performed in triplicate.
Heparan Sulfate Competitive Displacement Assay
Various amounts of heparan sulfate, dissolved in double-distilled water, were added into
each polyplex sample to achieve desired weight-to-weight ratios between heparan sulfate
and DNA. The mixtures were incubated at room temperature for another 15 min after which
3 μL of DNA sample buffer was added into each mixture. The final mixtures were loaded
onto a 1% agarose gel and electrophoresed for 30 min at 120 V. The gel was visualized with
ethidium bromide. For the PEI degradation study, each polymer was incubated at 37 °C for
0 h, 24 h, 72 h, and 192 h. Polyplexes and heparan sulfate displacement assay were prepared
as described above.
Dynamic Light Scattering
Based on the optimal transfection ratio, the corresponding amount of DNA and polymer
were diluted into 200 μL PIPES buffer to form the desired polymer and DNA weight–to-
weight ratio polyplexes. The polyplexes were incubated at room temperature for 15 min, and
double distilled water was added to reach a final sample volume of 2 mL. Polyplex size was
measured by Brookhaven Instruments Corporation 90 Plus Particle Size Analyzer
(Holtsville, NY) before and after 4 h of incubation at 37 °C. Each measurement was
repeated five times.
In Vitro Transfection
Cells (MDA-MB-231 or HeLa) were seeded in a 24-well plate at 8×104 cells/well in growth
medium with serum 24 h before transfection. On the day of transfection, growth medium
was replaced with fresh serum-free DMEM. Before transfection, 50 μL polyplexes in PIPES
buffer were formed with 0.5 μg pGL3 and various amount of polymer to achieve desired
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polymer/DNA ratios. The polyplexes were incubated at room temperature for 15 min and
added into each well. Four hours post-transfection, polyplexes were removed and replaced
with fresh growth medium with serum. Twenty-four hours post-transfection, luciferase
expression was determined using the Promega Luciferase Assay System (Promega), which
reports expression levels in relative light units (RLU) as measured on a Lumat L9507
luminometer (Berthold, GmbH, Germany). Each experiment was performed in
quadruplicate. Luciferase expression (RLUs) was normalized by total cell protein using
BCA Protein Assay Kit (Thermo Scientific, Rockford, IL).
Cytotoxicity Assay
The cytotoxicity of polymer on the MDA-MB-231 and HeLa cells was characterized using
the CellTiter 96 Non-Radioactive Cell Proliferation Assay (MTT) (Promega) according to
manufacturer’s protocol. Briefly, 8×103 cells/well were seeded in 96-well microplate in
growth medium containing 10% FBS. Twenty-four hours after seeding, the medium was
replaced with serum-free DMEM, and polymer was added to the cells to achieve a final
concentration between 0 and 50 μg/mL. Following a 4 h incubation period, the medium was
replaced with fresh serum-containing medium and incubated for another 24 h, after which
15 μL of the Dye Solution was added into each well, and cells were incubated for another 4
h. After incubation, 100 μL of the Solubilization Solution/Stop Mix was added into each
well and incubated for another 1 h. The absorbance at 570 nm, with reference wavelength of
650 nm, was measured using Tecan Safire 2 Fluorescence Reader (Tecan, Mannedorf,
Switzerland). The absorbance of medium was subtracted from the viable cell absorbance and
normalized to cells with no polymer. Each polymer and polymer concentration were tested
six times in each experiment.
Polyplex Uptake via Flow Cytometry
In a 24-well plate, 8×104 cells/well were seeded in growth medium with serum 24 h before
transfection. On the day of the transfection, growth medium was replaced with fresh serum-
free DMEM. The intercalating dye YOYO-1 (Invitrogen, Carlsbad, CA) was mixed with
pGL3 according to the ratio 25 nL YOYO-1/μg DNA. Fifty microliters of polyplexes in
PIPES buffer were formed with 0.5 μg pGL3/YOYO-1 and various amount of polymer to
achieve desired polymer/DNA ratios. Two hours post-transfection, the cells were trypsinized
and analyzed on a BD LSR II Flow Cytometer System (BD, Franklin Lakes, NJ). Median
peak fluorescence was recorded and normalized to cells transfected with pGL3/YOYO-1 in
the absence of polymer. Each measurement was performed in triplicate.
Results
Synthesis and characterization of biodegradable PEI
Three D.PEI samples were synthesized as described above by cross-linking equimolar
amounts of 800-Da, branched PEI and 1,6-hexanediol diacrylate, and catalyzed with 0.1,
0.15, and 0.2 molar equivalents of PVP(Fe(III)) catalyst per mole of PEI (Fig. 1). The
molecular weights of the resulting D.PEIs were 48 kDa, 6.2 kDa, and 1.2 kDa (termed
D.PEI-48, D.PEI-6.2, and D.PEI-1.2, respectively), determined using capillary viscometry
(Supplementary Table 1) (18). Compared to the 14 kDa and 30 kDa D.PEI generated by the
non-catalyzed reaction reported by Forrest et al. (15), the alternative synthesis reported here
provides a wider range of D.PEI molecular weights for characterization and gene delivery
studies.
The structure and degradation of polymeric gene delivery vectors are important parameters
for safe, efficient gene transfer. Non-degradable PEI may accumulate inside the cell,
increasing toxicity, and leading to reduced transfection efficiency (19). To investigate the
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structure and degradation of D.PEI samples, we incubated samples at 37 °C in D2O for
various amounts of time and obtained their 1H NMR spectra (Supplementary Figure 1). To
calculate the extent of D.PEI degradation, the relative number of protons from the methylene
group and the hydroxyl group adjacent to the carboxyl group was determined by integrating
the corresponding peaks in the spectra (20). The degradation rates of D.PEIs were
approximately the same (Fig. 2). D.PEI-1.2 degraded the most but all three D.PEIs have
~50% ester bond remaining after 24 h incubation.
Another D.PEI characteristic of interest is the degree of cross-linking. Highly cross-linked,
low molecular weight PEI is expected to behave similarly to its high molecular weight non-
cross-linked counterpart, including improved DNA binding and transfection efficiency, due
to similar molecular weights. By utilizing elemental analysis, we approximated the cross-
linking density of each D.PEI sample through mass balances (Table 1). As expected, the
higher molecular weight D.PEI possessed higher degree of cross-linking, and vice versa.
D.PEI-48, D.PEI-6.2, and D.PEI-1.2 exhibited cross-linking densities, defined as mole
percent of nitrogen atoms in PEI attached to 1,6-hexanediol diacrylate, of 16.9%, 15.1%,
and 14.1%, respectively. In addition to cross-linking density, it is also important to
understand the cross-linking structure of the D.PEIs. To determine whether the samples have
linear or branched structure, we calculated the number of PEI chains cross-linked with 1,6-
hexanediol diacrylate (Table 1) (21). The results show that D.PEI samples with higher cross-
link density have more diacrylates attached to a PEI chain. More importantly, all three
D.PEIs show that, on average, each sample has more than two diacrylates linked with a
single PEI chain. This finding implies that the D.PEI samples are branched. In particular, the
D.PEI-48 has more than three diacrylates attached to a PEI chain, which indicates a high
level of branching. Due to the loss of flexibility and steric hindrance as a result of this
branching, the D.PEIs tend not to condense DNA as efficiently as their unmodified 25 kDa
counterpart.
Characterization of D.PEI/DNA Polyplexes
One of the important characteristics of non-viral gene delivery vehicles is the ability to
condense DNA efficiently in order to be taken up by the cells. To determine the capability of
the polymers to bind DNA, we electrophoresed polyplexes formed at various polymer/DNA
ratios in agarose gel to observe the necessary amount of polymer needed to completely
inhibit DNA migration (Fig. 3). Unmodified 25-kDa, branched PEI required 0.2 μg
polymer/μg DNA to completely retard the DNA (Fig. 3A). The D.PEI samples retarded
DNA migration at 0.5 μg polymer/μg DNA (Fig 3B-3D). Upon closer examination,
D.PEI-48 prevented migration of most DNA at 0.3 μg D.PEI/μg DNA (Fig. 3B), while 0.4
μg D.PEI/μg DNA was needed for D.PEI-6.2 and D.PEI-1.2 (Fig. 3C and Fig. 3D). These
results indicate unmodified 25 kDa PEI bound DNA much more efficiently than D.PEI. This
observation may be attributed to a decrease in the number of protonated amines due to
attachment to the cross-linker, steric hindrance, or reduced flexibility due to the branched
D.PEI structure.
To be endocytosed, it is critical that the cationic polymer is able to form nanoscale
complexes with plasmid DNA (22). Dynamic light scattering was used to determine the size
of the polyplexes immediately after polyplex formation at each polymers’ optimal
transfection ratio, and again after 4 h incubation at 37 °C (Fig. 4). For all polymers, polyplex
size increased after incubation, likely due to aggregation. Unmodified 25 kDa PEI
polyplexes, at polymer/DNA ratio of 2:1 (w:w), exhibited the smallest effective diameter
both before and after incubation, despite these polyplexes containing 7.5-fold to 12.5-fold
less polymer by mass than the three D.PEI polyplexes, at polymer/DNA ratio of 15–25
(w:w). This result shows that unmodified 25 kDa PEI condensed plasmid DNA better than
the D.PEIs, which is consistent with the presence of higher cationic surface charges. For the
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D.PEIs, the polyplexes’ diameters were inversely related to the molecular weights of the
polymers before incubation. D.PEI-1.2 polyplexes showed the largest effective diameter,
even though there was ~1.6-fold more polymer present, confirming that higher molecular
weight PEI can condense DNA better than its lower molecular weight counterpart. The trend
is not as clear after 4 h of incubation, but the inverse relationship between molecular weight
and polyplex size among the D.PEI samples was still observed.
Polymeric gene delivery vectors should exhibit tight binding to plasmid DNA to protect and
avoid early release of DNA. To determine the “tightness” of DNA binding, we investigated
the polymer’s ability to exclude ethidium bromide, an intercalating dye that fluoresces much
more strongly when bound to double-stranded DNA. To quantify the degree of condensation
between D.PEIs and DNA, ethidium bromide fluorescence was measured in the presence of
polyplexes at various polymer/DNA ratios (Fig. 5). Unmodified 25 kDa PEI condensed
DNA tightly at polymer/DNA ratio of 0.5:1 (w:w) showing only 1% normalized
fluorescence. The D.PEI samples required more polymer, 0.5 μg, 1 μg, and 1 μg polymer/
μg DNA for D.PEI-48, D.PEI-6.2, and D.PEI-1.2, respectively, to achieve minimum
normalized fluorescence and similar DNA binding “tightness” as unmodified 25 kDa PEI.
This indicates that although all PEI samples are able to tightly condense DNA, D.PEIs
appear to form “looser” polyplexes than unmodified PEI.
Upon entering the cells, the DNA inside the polyplexes must be released in order for
transcription to occur. One way to measure the strength of the polymer/DNA binding is to
displace the DNA with a polyanion like heparan sulfate (HS). The amount of HS needed to
competitively displace DNA from polyplexes indicates the strength of binding (23). To
determine the relative DNA binding strength of the D.PEIs before and after degradation (0
to 192 hours incubation at 37 °C), along with unmodified 25 kDa and 800 Da PEIs, various
amounts of HS were added to polyplexes prepared at 2:1 (w:w) polymer/DNA ratio and
electrophoresed in agarose gel (Fig. 6). Twenty-five kDa and 800 Da PEI required ~18 μg
HS/μg DNA and 12 μg HS/μg DNA to displace the DNA, respectively (Fig. 6A and Fig.
6B). All the D.PEI samples required less HS compared to unmodified 25 kDa PEI, ~12 μg
HS/μg DNA, to dissociate the DNA (Fig. 6C–6N). This suggests that it is easier to
unpackage DNA from the D.PEIs than the unmodified PEI. Approximately the same amount
of HS was required for all D.PEI samples and for the 800 Da PEI, indicating that molecular
weight of the D.PEI is not the only factor that controls DNA binding. Due to steric effects
and loss of flexibility discussed previously, DNA can bind more strongly to the higher
overall positive charge of 25 kDa PEI than even the highest molecular weight of cross-
linked D.PEI. This explains why even the D.PEI-48 sample needs less HS to displace DNA
compared to the 25 kDa control.
In the tested incubation period, there is no significant change in the amount of HS needed to
release DNA from the polyplexes for all D.PEI samples. This is expected since D.PEIs and
800 Da PEI released DNA with the same amount of HS present. This could be due to the
relatively low cross-linking density of the D.PEIs, where the DNA binding of the
unmodified 800 Da PEI, the starting material of the D.PEI, might overwhelm the effect of
the reduced DNA binding strength from cross-link degradation.
In Vitro Transfection of D.PEI/DNA Polyplexes
Transfection efficacies of polyplexes formed with unmodified and cross-linked PEIs at
various polymer/DNA ratios were studied in HeLa and MDA-MB-231 cell lines (Fig. 7). In
HeLa cells, at the optimal polymer/DNA ratio (10:1 w:w), both D.PEI-48 and D.PEI-6.2
provided ~5–fold more transgene expression than unmodified, 25-kDa, branched PEI (PEI/
DNA = 2:1 w:w), while transgene expression with D.PEI-1.2 (D.PEI/DNA = 25:1 w:w) was
~3-fold greater than with unmodified PEI (Fig. 7A). In MDA-MB-231 cells, D.PEIs also
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mediated greater transgene expression than 25 kDa PEI, but not as significantly as in HeLa
cells (Fig. 7B). At their optimal polymer/DNA ratios, transgene expression mediated by
D.PEI-48 and D.PEI-6.2 (D.PEI/DNA = 15:1 w:w) was ~1.6–fold greater than unmodified
PEI (PEI/DNA = 2:1 w:w), while D.PEI-1.2 (D.PEI/DNA = 20:1 w:w) provided similar
transfection as unmodified PEI. The optimal polymer/DNA ratio was 2:1 for unmodified 25
kDa PEI in both HeLa and MDA-MB-231 cells. However, optimal polymer/DNA ratios for
D.PEIs were significantly higher (10–25:1 w:w), likely due to the weaker DNA
condensation and “looser” DNA binding compared to unmodified PEI.
Cytotoxicity of D.PEI
In order for the D.PEIs to be considered as potential vectors for gene delivery, they need to
exhibit low or no toxicity. To determine polymer toxicity, viability of HeLa and MDA-
MB-231 cells upon exposure to various amounts of polymers was measured using a MTT
assay (Fig. 8). Unmodified 25 kDa PEI reduced cell viability to 10% at polymer
concentrations greater than 15 μg/mL and 30 μg/mL in HeLa (Fig. 8A) and MDA-MB-231
(Fig. 8B) cells, respectively. All D.PEIs were significantly less cytotoxic in both cell lines
compared to unmodified PEI. D.PEI-48 was the most toxic of the three D.PEI samples; at 50
μg/mL (the maximum concentration investigated), it yielded 40% and 80% cell viability in
HeLa and MDA-MB-231 cells, respectively. D.PEI-1.2 was the least toxic polymer, causing
essentially no decrease in cell viability in both HeLa and MDA-MB-231 cells at 50 μg/mL.
At the same concentration, D.PEI-6.2 displayed 50% and 100% viability in the two cell
lines. All polymers were more cytotoxic to HeLa cells than MDA-MB-231 cells.
Cellular Uptake of D.PEI/DNA Polyplexes
The first step in the gene delivery process is cellular internalization of polyplexes, typically
by an endocytic mechanism. We measured uptake of fluorescently labeled polyplexes by
fluorescence-activated cell sorting (FACS) (Fig. 9). Overall, MDA-MB-231 cells
endocytosed 2- to 3-fold more polyplexes than HeLa cells for all polyplexes at the polymer/
DNA ratios tested. For unmodified 25 kDa PEI, approximately the same amount was
endocytosed at all polymer/DNA ratios in both HeLa and MDA-MB-231 cells. HeLa cells
internalized similar amounts of D.PEI and unmodified PEI polyplexes, except at polymer/
DNA = 25:1 (w:w), where the cells endocytosed slightly more D.PEI-48 polyplexes than
unmodified PEI polyplexes (Fig. 9A). Unlike HeLa cells, MDA-MB-231 cells endocytosed
more D.PEI polyplexes than unmodified PEI polyplexes, except at polymer/DNA = 2:1
(w:w) (Fig. 9B). At polymer/DNA ratios that resulted in the maximal uptake, D.PEI-48,
D.PEI-6.2, and D.PEI-1.2 polyplexes show 3-, 7-, and 4-fold higher cellular uptake than
unmodified PEI polyplexes, respectively.
Discussion
Safety and efficacy are arguably the most important factors in gene therapy. Polymers and
lipids have been optimized for gene delivery by chemically modifying their structures or by
conjugating ligands onto their surfaces (24). Specifically, the addition of degradable cross-
linker in branched PEI has been extensively investigated in order to reduce the cytotoxicity
and increase the transfection efficiency of branched PEI (11). We have further characterized
and optimized the branched PEI derivatives first reported by Forrest et al. due to their
relatively simple chemistry and efficient gene transfer (15).
Utilizing a heterogeneous PVP-supported Fe(III) catalyst, we synthesized a set of three
D.PEIs with a wide range of molecular weights (1.2–48 kDa) through Michael addition of
800-Da PEI to 1,6-hexanediol diacrylate, resulting in D.PEIs with ~15% cross-linking
density (Table 1). NMR confirmed the presence of ester linkages in each D.PEI and the
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degradation of the D.PEI when incubated at 37 °C (Fig. 2). Both gel retardation (Fig. 3) and
ethidium bromide exclusion (Fig. 5) studies indicated that all the D.PEIs were able to bind to
DNA as tightly as unmodified 25 kDa PEI (Fig. 3 and Fig. 5). At their optimal transfection
ratios, the D.PEI polyplexes were ~1.4-fold larger than the unmodified 25 kDa PEI
polyplexes, most likely due to the fact that the optimal D.PEI/DNA ratios for transfection
were 7- to 12-fold higher than that of 25 kDa PEI (Fig. 4). However, after a 4 h incubation,
which simulated the 4 h exposure of polyplexes to DMEM during transfection, aggregation
of D.PEI and 25 kDa PEI polyplexes resulted in similarly sized particles, making it unlikely
that polyplex size plays a major factor in the greater transfection efficiency of the D.PEIs.
All three D.PEIs mediated ~2- to 5-fold better transfection efficacy compared to unmodified
25 kDa PEI, in both HeLa and MDA-MB-231 cell lines, at their respective optimized
transfection ratios (Fig. 7). In particular, D.PEI-48 and D.PEI-6.2 consistently transfected
better than D.PEI-1.2 in both cell lines, which is consistent with findings that suggest
improved transfection efficiency with increasing PEI molecular weight (10). However, the
fact that D.PEI-48 required ~5- to 7-fold more polymer than unmodified 25 kDa PEI to
achieve optimal transfection indicates that, in addition to molecular weight, other factors
including cytotoxicity, cellular uptake and polyplex unpackaging may contribute to the
D.PEIs’ improved transfection efficiency.
Additionally, we demonstrated that the D.PEIs are less cytotoxic than unmodified 25 kDa
PEI. D.PEIs exhibited almost no toxicity in MDA-MB-231 cells; D.PEI-48 and D.PEI-6.2
reduced viability to ~50%, while D.PEI-1.2 was not toxic in HeLa cells at 50 μg/mL (Fig.
8). The optimal transfection ratio for 25 kDa PEI is 2:1 (w:w), which is approximately equal
to a PEI concentration of 2 μg/mL. This concentration corresponds to about 60% and 80%
viability for HeLa and MDA-MB-231 cell lines, respectively. Unlike unmodified PEI, our
D.PEIs show above 80% viability in HeLa cells and almost no toxicity in MDA-MB-231
cells at their respective optimal transfection ratios. This reduced toxicity partially explains
why transfection efficiency improved for D.PEI but decreased for unmodified PEI at
increasing polymer/DNA ratios above 2:1 (w:w).
As discussed previously, cellular uptake and DNA unpackaging are two important aspects of
gene delivery. HeLa cells internalized approximately the same amounts of unmodified PEI
and D.PEIs, except for D.PEI-48, while MDA-MB-231 cells internalized 2- to 7-fold more
D.PEI-containing polyplexes than unmodified PEI (Fig. 9). The increased cellular uptake of
D.PEIs over unmodified PEI in MDA-MB-231 cells is in good agreement with the gene
delivery activity of the polymers. However, this is not the case for HeLa cells, where there is
no significant difference in uptake to correlate with the increase in transfection. To explain
this discrepancy, we investigated the polymer’s ability in unpackaging DNA through
heparan sulfate competitive displacement assay. At the same polymer/DNA ratio, D.PEIs
more readily dissociated from DNA than unmodified 25 kDa PEI in the presence of heparan
sulfate (Fig. 6), which likely contributes to the increase in transfection efficiency for D.PEIs
in both HeLa and MDA-MB-231 cells. These results demonstrate that one must take
multiple intracellular barriers into account when designing potential non-viral gene delivery
vectors.
Compared to the biodegradable PEI first reported by Forrest et al. (15), this present work has
further characterized the D.PEI and investigated the effects of molecular weight on D.PEI-
mediated gene delivery. Forrest et al. synthesized 14 kDa and 30 kDa biodegradable PEI by
cross-linking 800 Da PEI with 1,3-butanediol diacrylate and 1,6-hexanediol diacrylate,
respectively, via Michael addition without catalyst and under different reaction conditions
than that reported here. Forrest et al. showed that their D.PEIs were capable of condensing
DNA, exhibited reduced toxicity, and improved transfection efficiency in several cell lines,
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but were unable to conclusively determine why the D.PEI were more effective than the 25
kDa control or the effect of D.PEI molecular weight on gene transfer activity. However, we
synthesized D.PEIs with a wide range of molecular weights, which has allowed us to
correlate D.PEI’s molecular weight with various gene delivery properties of cross-linked
PEI. Specifically, we have shown that the improved transfection efficiency of D.PEIs
compared to unmodified PEI is due to a combination of molecular weight, cytotoxicity,
polyplex internalization, and DNA unpackaging ability.
Several groups have reported various diacrylate cross-linked PEIs and shown at least 50-fold
improvement in transfection efficiency and reduced cytotoxicity compared to the controls
(25–26). However, it is difficult to draw a direct comparison between those polymers and
the polymers reported here, mainly due to the use of different cell lines and controls. In
addition, many of those reports only studied the effects of size, degradability, and
cytotoxicity of the cross-linked PEI polyplexes on transfection, but neglected the effects of
intracellular barriers including cellular uptake and polyplex unpackaging on gene delivery.
Without such characterization, it is not possible to fully understand or compare cross-linked
PEIs as polymeric gene delivery vectors and to explain relative enhancement in gene
transfer ability.
Conclusions
We reported a controllable synthesis of biodegradable PEI by cross-linking 800 Da PEI and
1,6-hexanediol diacrylate by Michael addition via a polymer-supported heterogeneous
catalyst. The resulting polymers have a wider range of molecular weights and have
demonstrated 2- to 5-fold more efficient gene transfer compared to commercially available,
25 kDa PEI. The improvement in gene delivery of these D.PEIs is likely due to a
combination of their low cytotoxicity, easy DNA unpackaging, and high cellular uptake.
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Refer to Web version on PubMed Central for supplementary material.
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Synthesis of biodegradable PEI derivatives. 800 Da PEI is cross-linked with 1,6-hexanediol
diacrylate in methanol overnight at 60°C, catalyzed by PVP(Fe(III)) heterogenous catalyst.
The diacrylate groups can react with primary and secondary amines of the PEI.
Shum et al. Page 12














Degradation of D.PEIs in D2O at 37 °C for various incbuation periods. Degradation was
calculated based on the integrals of the ester linker and hydrolyzed ester linker peaks
determined by 1H-NMR.
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Gel retardation of polymer/DNA polyplexes. (A) Unmodified 25 kDa PEI, (B) D.PEI-48,
(C) D.PEI-6.2, (D) D.PEI-1.2. The polymer to DNA weight-to-weight ratio for each
polyplex is listed above the corresponding lane.
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The effective diameters of unmodified 25 kDa PEI and three D.PEIs’ polyplexes before and
after 4 hours incubation at 37°C, at their respective optimal transfection ratio (N=3, error
bars represent standard deviation). The symbols (*, **, ***, ****, †, ‡, ^) indicate pairwise
comparisons by t-test with p < 0.01.
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Ethidium bromide exclusion assay. Polyplexes were formed with unmodified 25 kDa PEI or
D.PEIs with DNA at various ratios in the presence of ethidium bromide. Normalized
fluorescence was calculated by (F−F0)/(FDNA−F0). F, fluorescence of polyplexes and
ethidium bromide; F0, fluorescence of ethidium bromide only; FDNA, fluorescence of DNA
and ethidium bromide (N=3, error bars represent standard deviation).
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Heparan sulfate displacement of polymer/DNA polyplexes at 2:1 (w:w) ratio. D.PEIs were
incubated at 37 °C for 0, 24, 72, and 192 hours before complexation with DNA. (A)
unmodified 25 kDa PEI, (B) unmodified 800 Da PEI, (C–F) D.PEI-48, (G–J) D.PEI-6.2,
(K–N) D.PEI-1.2. The heparan sulfate/DNA ratio (w:w) for each polyplex is given above
the corresponding lane.
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In vitro transfection of (A) HeLa cells and (B) MDA-MB-231 cells with polyplexes formed
with pGL3 and unmodified 25 kDa PEI or D.PEIs at various polymer/DNA ratios (t-test: †,
p < 0.01; ‡, p < 0.01; *, p < 0.01). Luciferase expression in the cell lysates is reported as
relative light unit (RLU) normalized by the total amount of protein the cell lysates (N=4,
error bars represent standard deviation).
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Cytotoxicity of biodegradable PEI derivatives reported as normalized metabolic activity in
(A) HeLa cells and (B) MDA-MB-231 cells in the presence of varying amounts of
unmodified 25 kDa PEI and D.PEIs (ANOVA: †, D.PEI-48, p < 0.05; ‡, D.PEI-6.2, p <
0.05; *, D.PEI-1.2, p < 0.05). Metabolic activity was normalized to control with no polymer
present (N=6, error bars represent standard deviation).
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Cellular uptake of polyplexes containing YOYO-1 intercalated pGL3 in (A) HeLa cells and
(B) MDA-MB-231 cells (t-test: †, p < 0.01; ‡, p < 0.01; *, p < 0.01). Results are reported as
median fluorescence normalized by control with no polymer present using FACS (N=3,
error bars represent standard deviation).
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